2017
DOI: 10.1016/j.molimm.2017.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Scaffold protein JLP mediates TCR-initiated CD4 + T cell activation and CD154 expression

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“… 75 Furthermore, SPAG9 deficient mouse models demonstrated that SPAG9 plays a key role in regulating CD4+ T cells response to TCR stimulation. 76 Silencing of SPAG9 has been shown to arrest cancer cells in G0/G1 or S phase and decrease expression of cyclins and cyclin-dependent kinases. 77 , 78 , 79 , 80 , 81 , 82 , 83 SPAG9 silencing in combination with paclitaxel treatment synergistically inhibited ovarian cancer cell viability, and SPAG9 depletion in ovarian cancer xenograft mouse models significantly reduced tumor growth.…”
Section: Genomic Integrity-regulatory Ctasmentioning
confidence: 99%
“… 75 Furthermore, SPAG9 deficient mouse models demonstrated that SPAG9 plays a key role in regulating CD4+ T cells response to TCR stimulation. 76 Silencing of SPAG9 has been shown to arrest cancer cells in G0/G1 or S phase and decrease expression of cyclins and cyclin-dependent kinases. 77 , 78 , 79 , 80 , 81 , 82 , 83 SPAG9 silencing in combination with paclitaxel treatment synergistically inhibited ovarian cancer cell viability, and SPAG9 depletion in ovarian cancer xenograft mouse models significantly reduced tumor growth.…”
Section: Genomic Integrity-regulatory Ctasmentioning
confidence: 99%